Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|June 1, 1997
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)G Socié, J Y Cahn, J Carmelo, et al.
Leukemia|December 1, 1996
Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 studyJ Reiffers, A M Stoppa, M Attal, et al.
Bone Marrow Transplantation|December 3, 2013
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)P Chevallier, M Labopin, N Milpied, et al.
Leukemia|October 1, 2010
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie CellulaireM Mohty, M Labopin, M L Balère, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2016
A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complicationA Conrad, M Le Maréchal, D Dupont, et al.
British Journal of Haematology|February 14, 2002
Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukaemiaA Pigneux, M L Tanguy, M Michallet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 8, 2012
Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008)A Xhaard, F Lanternier, R Porcher, et al.
Leukemia & Lymphoma|December 30, 1998
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemiaD Maraninchi, N Vey, P Viens, et al.
Bone Marrow Transplantation|November 4, 2014
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)M Y Detrait, S Morisset, R Peffault de Latour, et al.
Bone Marrow Transplantation|January 17, 2017
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMTG Battipaglia, M Labopin, A Candoni, et al.
Pageof 16